Grand China Capital
Overview
Grand China Capital is a private equity and venture capital firm based in Shenzhen, China, that invests in a diversified range of industries including artificial intelligence, technology, and manufacturing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Moffett AI | Jan 2022 | Series A | Co-investor |
| Jiangsu Zhenyi Medical Technology Co., Ltd. | May 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Grand China Capital based?
Grand China Capital is headquartered in Shenzhen, China.
When was Grand China Capital founded?
Grand China Capital was founded in 2014.
How many portfolio companies does Grand China Capital have?
Grand China Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Grand China Capital's portfolio?
Portfolio companies visible on Caplight include Moffett AI, Jiangsu Zhenyi Medical Technology Co., Ltd..
What was Grand China Capital's most recent investment shown here?
Grand China Capital's most recent investment in this portfolio sample was in Moffett AI in 2022.
What sectors does Grand China Capital focus on?
Grand China Capital focuses on Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Grand China Capital focus on?
Grand China Capital typically invests at the Early stage.